What Is the International Myeloma Foundation's (IMF) Global Myeloma Action Network, or GMAN?
GMAN is a global coalition of myeloma patient organizations representing over 40 countries.
GMAN works in collaboration with patients, caregivers, physicians/KOLs, policymakers, the pharmaceutical industry and other global stakeholders.
While each member organization executes its own vision and mission, GMAN works to increase global awareness of multiple myeloma, improve access to timely diagnosis and critical medicines as well as provide capacity-building support to our national member organizations.
Learn More About the IMF's Global Advocacy Initiative
What Is Multiple Myeloma?
Our bone marrow creates plasma cells that make antibodies, which play an important role in fighting off viruses and bacteria. Multiple myeloma causes the bone marrow to create dysfunctional antibodies and plasma cells. A malignant plasma cell or cancer cell is referred to as a myeloma cell.
Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.
Myeloma is a cancer of the plasma cells in the bone marrow. The malignant plasma cells, or myeloma cells, accumulate in the bone marrow. These myeloma cells are abnormal plasma cells that divide uncontrollably, leading to the overproduction of dysfunctional antibodies and crowding out healthy blood cells.